Frontlight ResearchEarly access
Trial site
ICANS - Institut de cancérologie Strasbourg Europe
- 4running trials
- 4closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Ovarian cancer3 trials
- Head and neck cancer2 trials
- Lung cancer2 trials
- Prostate cancer2 trials
- Bladder cancer1 trial
- Childhood cancers1 trial
- Colorectal cancer1 trial
- Endometrial cancer1 trial
- Kidney cancer1 trial
- Liver and biliary tract cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 1/23 trials
- Phase 22 trials
- Phase 31 trial
- Status
- Completed4 trials
- Recruiting3 trials
- Active, not recruiting1 trial
- Lead sponsor
- ARCAGY/ GINECO GROUP2 trials
- Galecto Biotech AB1 trial
- Incyte Biosciences International Sàrl1 trial
- Institut Cancerologie de l'Ouest1 trial
- Ipsen1 trial
- and 2 more
Running trials
Recruiting
Recruiting
Addition of Pembrolizumab to the Standard of Care Chemotherapy in Patient With SCCOHT
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Ovarian cancer3 recruiting
- Childhood cancers1 recruiting
- Colorectal cancer1 recruiting
- Endometrial cancer1 recruiting
- Head and neck cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
- Lung cancer1 recruiting
- Prostate cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026